Alberto Alvarez-Larrán et al.
Annals of hematology, 93(12), 2037-2043 (2014-07-02)
Therapeutic options for patients with polycythemia vera (PV) and essential thrombocythemia (ET) resistant or intolerant to hydroxyurea are limited. Busulfan is effective as first-line therapy, but there is scarce information on this drug as second-line treatment. The efficacy of busulfan